Skip to search formSkip to main contentSkip to account menu

cerulomycin

Known as: caerulomycin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

2,2'-Dipyridyl
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis
Abstract Multiple sclerosis (MS) is a highly detrimental autoimmune disease of the central nervous system. There is no cure for… 
2015
2015
Caerulomycin A inhibits Th2 cell activity: a possible role in the management of asthma
We have recently demonstrated that Caerulomycin A induces regulatory T cells differentiation by suppressing Th1 cells activity… 
2015
2015
Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content
Recently, we have described the use of caerulomycin A (CaeA) as a potent novel immunosuppressive agent. Immunosuppressive drugs… 
Highly Cited
2014
Highly Cited
2014
Reductive couplings of 2-halopyridines without external ligand: phosphine-free nickel-catalyzed synthesis of symmetrical and unsymmetrical 2,2'-bipyridines.
An unexpectedly facile synthetic approach for symmetrical and unsymmetrical 2,2'-bipyridines through the Ni-catalyzed reductive… 
2014
2014
Caerulomycin A—An Antifungal Compound Isolated from Marine Actinomycetes
Actinomycetes have been prolific sources of novel secondary metabolites with a range of biological activities that may ultimately… 
2014
2014
Caerulomycin A Enhances Transforming Growth Factor-β (TGF-β)-Smad3 Protein Signaling by Suppressing Interferon-γ (IFN-γ)-Signal Transducer and Activator of Transcription 1 (STAT1) Protein Signaling…
Background: Caerulomycin A, a known antifungal agent, was explored for its novel immunomodulatory activity. Results: Caerulomycin… 
2013
2013
Engineered reversal of drug resistance in cancer cells—metastases suppressor factors as change agents
Building molecular correlates of drug resistance in cancer and exploiting them for therapeutic intervention remains a pressing… 
2004
2004
Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity againstEntamoeba histolytica
The anti-amoebic action of the bipyridyl antibiotic caerulomycin was assessed in vitro and in vivo using various strains… 
1996
1996
First Synthesis of Caerulomycin C.
The first synthesis of caerulomycin C (1), an antibiotic produced by Streptomyces caeruleus, is reported. This molecule, which… 
Review
1959
Review
1959
Identification of an alkaline-dependent Streptomyces as Streptomyces caeruleus Baldacci and characterization of the species under controlled conditions.
  • W. A. Taber
  • Canadian Journal of Microbiology (print)
  • 1959
  • Corpus ID: 162013
The identity of the Streptomyces which produces the new crystalline antibiotic, caerulomycin, was determined. The distinctive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)